Affichage de 1 résultats
Description archivistique![[E] CARRICK THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 CLINICAL TRIAL OF ITS ORAL CDK7 INHIBITOR: CT7001](/uploads/r/null/4/9/4/494782a7dbf62a5829391e372d7fd5356874294754f2ca01df2f8373a01f08d9/5c8988ad-3dd8-41a8-955d-865bd4eee937-_E__carricktherapeutics-first-patient-dosed-2020-12-01-08_46_23_142.jpg)
[E] CARRICK THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 CLINICAL TRIAL OF ITS ORAL CDK7 INHIBITOR: CT7001
- Presse-papier Presse-papier
-
Langue
Langue
-
Langue
- English
- Français
- Español
- Nederlands
- Português
-
-
Liens rapides
Liens rapides
-
Liens rapides
- Aide
-